HealthAugust 12, 2026
venetoclax
vuh-NET-oh-klaks
Definition
A targeted cancer medication often used in combination therapies to treat specific types of leukemia.
Etymology
The name is a brand-name pharmaceutical portmanteau, likely derived from combining 'veneto-' (possibly suggesting a connection to B-cell lymphoma-2, or BCL-2, which it inhibits) and the suffix '-clax' commonly used in oncology drug naming.
In the news
The article mentions venetoclax as a standard therapy that Kura Oncology's drug, KOMZIFTI, is being combined with by physicians to treat patients with relapsed/refractory AML.
Earnings call transcript: Kura Oncology tops Q2 2026 estimates as launch gains
Read the full article ↗Investing.com